Zoetis Inc

Common Name

Zoetis

Country

United States

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

13,800

Ticker

ZTS

Exchange

NEW YORK STOCK EXCHANGE, INC.

Website

www.zoetis.com

Description

Zoetis Inc. is a global leader in the animal healthcare sector, specializing in the development, manufacture, and commercialization of a diverse range of medicines and vaccines for pets and livestock.... Show more

Financial Statements of Zoetis

Below are the financial statements of Zoetis, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of USD	2024	2023
Assets	—	—
Cash and cash equivalents	1,987^a	2,041^a
Accounts receivable, less allowance for doubtful accounts	1,316^a	1,304^a
Inventories	2,306^a	2,564^a
Other current assets	377^a	434^a
Total current assets	5,986^a	6,343^a
Property, plant and equipment, less accumulated depreciation	3,391^a	3,204^a
Operating lease right-of-use assets	219^a	230^a
Goodwill	2,724^a	2,759^a
Identifiable intangible assets, less accumulated amortization	1,127^a	1,338^a
Noncurrent deferred tax assets	540^a	206^a
Other noncurrent assets	250^a	206^a
Total assets	14,237^a	14,286^a
Liabilities and equity	—	—
Short-term borrowings	0^a	3^a
Current portion of long-term debt	1,350^a	0^a
Accounts payable	433^a	411^a
Dividends payable	224^a	198^a
Accrued expenses	746^a	683^a
Accrued compensation and related items	441^a	382^a
Income taxes payable	93^a	110^a
Other current liabilities	125^a	102^a
Total current liabilities	3,412^a	1,889^a
Long-term debt, net of discount and issuance costs	5,220^a	6,564^a
Noncurrent deferred tax liabilities	167^a	146^a
Operating lease liabilities	174^a	188^a
Other taxes payable	272^a	271^a
Other noncurrent liabilities	222^a	237^a
Total liabilities	9,467^a	9,295^a
Stockholders' equity	—	—
Common stock	5^a	5^a
Treasury stock, at cost	-7,445^a	-5,597^a
Additional paid-in capital	1,182^a	1,133^a
Retained earnings	11,968^a	10,295^a
Accumulated other comprehensive loss	-940^a	-839^a
Total Zoetis Inc. equity	4,770^a	4,997^a
Equity attributable to noncontrolling interests	0^a	-6^a
Total equity	4,770^a	4,991^a
Total liabilities and equity	14,237^a	14,286^a

Verified Sources Behind Zoetis’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Zoetis’s data sources below and access millions more through our Disclosure Search.

a. Zoetis's 10-K 2024

Trace every data point back to Zoetis’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Zoetis Inc

Financial Statements of Zoetis

Verified Sources Behind Zoetis’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

Neurocrine Biosciences Inc

United Therapeutics Corp

Viatris Inc

Stryker Corp

Brightspring Health Services Inc

Quest Diagnostics Inc